Dana Flanders
Stock Analyst at Guggenheim
(0.16)
# 4,358
Out of 5,006 analysts
7
Total ratings
16.67%
Success rate
-13.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Dana Flanders
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VALN Valneva SE | Maintains: Buy | $17 → $15 | $11.39 | +31.69% | 1 | Mar 24, 2025 | |
| SCYX SCYNEXIS | Initiates: Buy | $25 | $0.80 | +3,025.00% | 1 | Jan 22, 2021 | |
| PCRX Pacira BioSciences | Initiates: Neutral | n/a | $24.84 | - | 1 | May 27, 2020 | |
| HRTX Heron Therapeutics | Initiates: Buy | $24 | $1.32 | +1,718.18% | 1 | May 27, 2020 | |
| COLL Collegium Pharmaceutical | Initiates: Neutral | n/a | $34.61 | - | 1 | May 27, 2020 | |
| EBS Emergent BioSolutions | Upgrades: Buy | $60 → $75 | $9.15 | +719.67% | 2 | Nov 2, 2018 |
Valneva SE
Mar 24, 2025
Maintains: Buy
Price Target: $17 → $15
Current: $11.39
Upside: +31.69%
SCYNEXIS
Jan 22, 2021
Initiates: Buy
Price Target: $25
Current: $0.80
Upside: +3,025.00%
Pacira BioSciences
May 27, 2020
Initiates: Neutral
Price Target: n/a
Current: $24.84
Upside: -
Heron Therapeutics
May 27, 2020
Initiates: Buy
Price Target: $24
Current: $1.32
Upside: +1,718.18%
Collegium Pharmaceutical
May 27, 2020
Initiates: Neutral
Price Target: n/a
Current: $34.61
Upside: -
Emergent BioSolutions
Nov 2, 2018
Upgrades: Buy
Price Target: $60 → $75
Current: $9.15
Upside: +719.67%